Chitosan nanoparticles as delivery systems for doxorubicin

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology

Background:

• Chitosan nanoparticles are promising drug delivery systems.
• Encapsulating hydrophilic drugs like doxorubicin (DOX) in chitosan nanoparticles presents challenges due to charge interactions.
• Developing effective strategies for drug loading and controlled release is crucial for therapeutic applications.

Purpose of the Study:

• To evaluate chitosan nanoparticles as carriers for doxorubicin (DOX).
• To overcome the challenge of encapsulating the cationic, hydrophilic drug DOX into chitosan nanoparticles.
• To investigate different complexation methods to enhance DOX loading and controlled release.

Main Methods:

• Complexation of DOX with dextran sulfate to mask its positive charge.
• Formation of chitosan nanoparticles via ionic gelation.
• In vitro drug release studies using fluorimetric analysis.
• Cell culture studies to evaluate the cytostatic activity of DOX-loaded nanoparticles.
• Confocal microscopy to track nanoparticle uptake and drug localization within cells.

Main Results:

• Complexing DOX with dextran sulfate doubled encapsulation efficiency, achieving up to 4.0 wt.% DOX loading.
• DOX-loaded nanoparticles exhibited an initial release phase followed by very slow release.
• Nanoparticles containing dextran sulfate maintained DOX's cytostatic activity in cell cultures.
• Confocal studies confirmed cellular uptake of DOX associated with nanoparticles, not free drug.

Conclusions:

• Chitosan nanoparticles are feasible carriers for the hydrophilic drug doxorubicin (DOX).
• Complexation with dextran sulfate is an effective strategy to improve DOX encapsulation and maintain its activity.
• These nanoparticles can deliver active DOX into cells, showing potential for cancer therapy.